Lantern Pharma Inc. , a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process.
Lantern Pharma stock last closed at $5.39, up 5.69% from the previous day, and has increased 8.67% in one year. It has overperformed other stocks in the Biotechnology industry by 0.3 percentage points. Lantern Pharma stock is currently +126.47% from its 52-week low of $2.38, and -55.05% from its 52-week high of $11.99.
At the moment, there are 10.74M shares of LTRN outstanding. The market value of LTRN is $57.90M. In the past 24 hours, 122,978 LTRN shares were traded.
You will need a brokerage account to access the NASDAQ market and buy LTRN shares.
Based on our analysis, eToro is the best online stock brokerage. Here's why:
Get $10 towards your stock purchase by creating an account with eToro now.
Open eToro AccountNow that you've picked your brokerage, the next step is to fill out some personal information so you can buy LTRN today.
Now that you have created your account on the best stock trading app for beginners, you need to deposit funds:
Check out the tutorial below if you need help depositing money into your new investment account.
After you have chosen the best place to buy Lantern Pharma stock, it's very important to evaluate their stock prior to investing, so you truly comprehend the risk as well as the upside.
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis.
You can see all of the due diligence checks on LTRN's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge LTRN's fair value.
Using relative valuations ratios:
You can do additional valuation research on LTRN's stock here.
You can dig deeper into what analysts are projecting on the Lantern Pharma stock forecast page.
Over the last 12 months, insiders at LTRN have sold more shares than they have bought.
Aaron Gl Fletcher, 10% Owner of LTRN, was the latest LTRN insider to sell. They sold $20,380.95 worth of LTRN shares on Feb 29, 2024.
Dig into more about who owns LTRN shares here.
No, Lantern Pharma doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
There are two primary types of orders:
Press the Open button and eToro will execute your order.
If you need more help with investing in stocks on eToro, click the helpful video below:
Now that you own some LTRN stock, you'll want to keep up with your company.
Start a watchlist to get notified of the latest news about your LTRN stock.
To reiterate, here are the 6 steps to buy stock in Lantern Pharma:
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to keep an eye on your investment in Lantern Pharma, click the button below.